Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy (METACIN): a Randomized Double-blind Controlled Trial

NCT05786599 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT05786599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05786599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy (METACIN): a Randomized Double-blind Controlled Trial
Lead sponsor
University of British Columbia
Phase
Phase 2/3
Overall status
Recruiting
Start date
March 21, 2025
Completion date
March 31, 2026
Enrollment
50 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy